| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.11B | $786.3M | $544.0M |
| YoY Revenue Growth % | +41.5% | +44.5% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $89.6M | $58.8M | $50.1M |
| Operating Margin % | 8.1% | 7.5% | 9.2% |
| Net Income (GAAP) | $11.7M | $15.3M | $39.1M |
| EBITDA (Normalized) | $106.6M | $75.3M | $69.7M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $27.0M | -$31.0M | -$21.8M |
| Capital Expenditures (CapEx) | $21.3M | $20.7M | $24.5M |
| Free Cash Flow (FCF) | $5.7M | -$51.7M | -$46.3M |
| FCF Margin % | 0.5% | -6.6% | -8.5% |
| Return on Invested Capital (ROIC %) | 4.3% | 3.4% | 2.7% |
| Cash & Short-Term Equivalents | $69.4M | $29.5M | — |
| Total Debt (Short + Long Term) | $285.3M | $400.2M | $559.9M |
| Total Stockholders' Equity | $1.44B | $988.2M | $1.15B |